Biologically pure faecalibacterium butyricigenerans strain, composition including the same and method for treating inflammation-related disease
AssigneeBgi Shenzhen
InventorsYuanqiang ZOU, Wenbin XUE, Liang XIAO, Xiaoping LI, Jinghong YU, Chuan LIU
Life of this patent
Estimating the term…
Abstract
Provided are a biologically pure Faecalibacterium butyricigenerans strain AF52-21 deposited under CGMCC Accession No. 1.5206 and a composition including the same and a carrier. A method for treating an inflammation-related disease in a subject in need thereof is also provided.
Claims21
A biologically pure Faecalibacterium butyricigenerans strain AF52-21, deposited under CGMCC Accession No. 1.5206.
A method for treating an inflammation-related disease in a subject in need thereof, comprising orally administrating a composition comprising a therapeutic effective amount of Faecalibacterium butyricigenerans AF52-21 deposited under CGMCC Accession No. 1.5206, to the subject in need thereof.
Dependencies are inferred from the claim text.